|
Catalog Number 08K41-28 |
Device Problem
High Test Results (2457)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 10/10/2023 |
Event Type
malfunction
|
Event Description
|
The customer reported falsely elevated architect insulin, which was not consistent with patient's clinical presentation and/or history and provided the following data for 1 patient: insulin laboratory results: (unit of measure is uu/ml) (b)(6) 2023 result was 144.5, 12 oct 2023 result was 130.6, 23 oct 2023 result was 123.2, roche result was 22.91 (date unknown).Other laboratory results: a1c = 6.8%, fasting glucose = 154.71, insulin resistance = 8.8.There was no reported impact to patient management.
|
|
Manufacturer Narrative
|
All available patient information was included.Additional patient details are not available.An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.
|
|
Event Description
|
The customer reported falsely elevated architect insulin, which was not consistent with patient's clinical presentation and/or history and provided the following data for 1 patient: insulin laboratory results: (unit of measure is uu/ml).(b)(6) 2023 result was 144.5.(b)(6) 2023 result was 130.6.(b)(6) 2023 result was 123.2.Roche result was 22.91 (date unknown).Other laboratory results: a1c = 6.8%.Fasting glucose = 154.71.Insulin resistance = 8.8.There was no reported impact to patient management.
|
|
Manufacturer Narrative
|
The complaint investigation included a review of data and information provided by the customer, search for similar complaints, ticket trending review, labeling review, device history record review, and field data review.Return testing was not completed as returns were not available.Data and information provided by the customer were reviewed and support the complaint issue without indication for any additional issue.The ticket search by lot did not identify an increase in complaint activity.Ticket and trending review did not identify any trends related to customer reported event.Device history review did not identify any non-conformances, potential non-conformances or deviations with the complaint lot and customer reported event.The overall performance of the architect insulin reagent in the field was reviewed using data gathered from customers worldwide.The review of field data indicated that the patient median result for lot 54221lp21 is within the established control limits.Therefore, no unusual reagent lot performance was identified.Labeling was reviewed and sufficiently addresses the customer¿s reported issue.Based on the investigation, no systemic issue or deficiency was identified for the architect insulin reagent lot 54221lp21.
|
|
Search Alerts/Recalls
|
|
|